Table 3 Use of paracetamol and the severity of preeclampsia in cases (n=1,252) and controls (n=1,256).

< 15 GWs

32 (1.3)

19 (1.5)

13 (1.0)

1.48 (0.72–3.01)

0.279

1.48 (0.67–3.24)

0.331

9 (1.2) mild

1.20 (0.51–2.81)

0.680

1.16 (0.46–2.92)

0.752

10 (1.9) severe

1.88 (0.82–4.32)

0.136

1.95 (0.79–4.80)

0.146

≥ 15 and < 29 GWs

38 (1.5)

25 (2.0)

13 (1.0)

1.96 (1.00–3.85)

0.051

2.06 (0.95–4.45)

0.067

13 (1.8) mild

1.74 (0.80–3.77)

0.161

1.89 (0.81–4.45)

0.143

12 (2.3) severe

2.27 (1.03–5.00)

0.043

2.30 (0.94–5.60)

0.067

≥ 29 GWs

51 (2.0)

45 (3.6)

6 (0.5)

7.81 (3.32–18.37)

< 0.001

7.63 (3.14–18.55)

< 0.001

29 (4.0) mild

8.65 (3.57–20.93)

< 0.001

8.50 (3.40–21.17)

< 0.001

16 (3.1) severe

6.64 (2.58–17.07)

< 0.001

6.36 (2.38–16.94)

< 0.001

Unknown

16 (0.6)

11 (0.9)

5 (0.4)

All paracetamol users

137(5.5)

100 (8.0)

37 (2.9)

2.86 (1.95–4.21)

< 0.001

2.84 (1.86–4.32)

< 0.001

All women

2508 (100)

1252 (100)

1256 (100)